Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cryptogenic Organizing Pneumonia.
King TE Jr, Lee JS. King TE Jr, et al. N Engl J Med. 2022 Mar 17;386(11):1058-1069. doi: 10.1056/NEJMra2116777. N Engl J Med. 2022. PMID: 35294814 Review. No abstract available.
Lessons From an Educational Never Event.
Lucey CR, Navarro R, King TE Jr. Lucey CR, et al. Among authors: king te jr. JAMA Intern Med. 2017 Oct 1;177(10):1415-1416. doi: 10.1001/jamainternmed.2017.3055. JAMA Intern Med. 2017. PMID: 28846754 No abstract available.
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
Morisset J, Vittinghoff E, Lee BY, Tonelli R, Hu X, Elicker BM, Ryu JH, Jones KD, Cerri S, Manfredi A, Sebastiani M, Gross AJ, Ley B, Wolters PJ, King TE Jr, Kim DS, Collard HR, Lee JS. Morisset J, et al. Among authors: king te jr. Respir Med. 2017 Jun;127:51-56. doi: 10.1016/j.rmed.2017.04.012. Epub 2017 Apr 22. Respir Med. 2017. PMID: 28502419 Free PMC article.
The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.
Brownell R, Moua T, Henry TS, Elicker BM, White D, Vittinghoff E, Jones KD, Urisman A, Aravena C, Johannson KA, Golden JA, King TE Jr, Wolters PJ, Collard HR, Ley B. Brownell R, et al. Among authors: king te jr. Thorax. 2017 May;72(5):424-429. doi: 10.1136/thoraxjnl-2016-209671. Epub 2017 Jan 12. Thorax. 2017. PMID: 28082530 Free PMC article.
A diagnostic model for chronic hypersensitivity pneumonitis.
Johannson KA, Elicker BM, Vittinghoff E, Assayag D, de Boer K, Golden JA, Jones KD, King TE Jr, Koth LL, Lee JS, Ley B, Wolters PJ, Collard HR. Johannson KA, et al. Among authors: king te jr. Thorax. 2016 Oct;71(10):951-4. doi: 10.1136/thoraxjnl-2016-208286. Epub 2016 May 31. Thorax. 2016. PMID: 27245779 Free PMC article.
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis.
Nathan SD, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Glasscock KF, King TE Jr, Lancaster L, Lederer DJ, Lin Z, Pereira CA, Swigris JJ, Valeyre D, Noble PW, Wells AU. Nathan SD, et al. Among authors: king te jr. Thorax. 2016 May;71(5):429-35. doi: 10.1136/thoraxjnl-2015-207011. Epub 2016 Mar 11. Thorax. 2016. PMID: 26968970 Free PMC article. Clinical Trial.
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
Lancaster L, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, King TE Jr, Lederer DJ, Lin Z, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, Noble PW. Lancaster L, et al. Among authors: king te jr. BMJ Open Respir Res. 2016 Jan 12;3(1):e000105. doi: 10.1136/bmjresp-2015-000105. eCollection 2016. BMJ Open Respir Res. 2016. PMID: 26835133 Free PMC article.
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Noble PW, Albera C, Bradford WZ, Costabel U, du Bois RM, Fagan EA, Fishman RS, Glaspole I, Glassberg MK, Lancaster L, Lederer DJ, Leff JA, Nathan SD, Pereira CA, Swigris JJ, Valeyre D, King TE Jr. Noble PW, et al. Among authors: king te jr. Eur Respir J. 2016 Jan;47(1):243-53. doi: 10.1183/13993003.00026-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647432 Free PMC article.
207 results